trending Market Intelligence /marketintelligence/en/news-insights/trending/HywFcR2Nnh-X2TXds7l9fQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Can-Fite BioPharma to raise $5M in registered direct offering

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Can-Fite BioPharma to raise $5M in registered direct offering

Can-Fite BioPharma Ltd. is looking to raise $5 million in a registered direct offering of American depositary shares.

The company plans to issue 2.5 million ADS at $2 apiece, complete with warrants to purchase another 1.25 million ADS at $2.25 apiece.

The warrants are exercisable after six months from the date of issue and expire within a 5.5- year period.

The offering closes Jan. 24, with Rodman & Renshaw acting as the exclusive placement agent for the offering.